FSH & LH, SERUM Test in Chennai

This test is used as an adjunct in the evaluation process of menstrual irregularities. This test is also used to assess the patients with suspected hypogonadism, predict the ovulation, help in diagnosing pituitary disorders and even evaluate infertility.

Test type Blood
Pre-test Information Days of menstrual cycle has to be specified. Generally, day 2 or 3 of the menstrual cycle is preferred for sample collection.
Report Delivery Same Day
Components -
Price ₹ 990

Info for Doctor

Abnormal LH levels are interpreted with increased or decreased levels of other fertility hormones such as FSH estrogens progesterone and testosterone. Increased LH levels are associated primary ovarian hypogonadism and gonadotropin secreting pituitary tumors. Decreased LH levels are associated with Hypothalamic GnRH deficiency, Pituitary LH deficiency, Ectopic steroid hormone production, GnRH analog treatment. FSH Abnormal FSH levels are interpreted with increased or decreased levels of other fertility hormones such as LH estrogens progesterone and testosterone. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased FSH levels are associated with primary ovarian hyperfunction in females and primary hypergonadism in males. Normal or decreased FSH levels are associated with polycystic ovary disease in females. COAGULATION CG0001 PROTHROMBIN TIME (PT/INR) REFERENCE GROUP INTERNATIONAL NORMALIZED RATIO (INR) NORMAL POPULATION 0.9 - 1.1 PATIENTS ON ANTICOAGULANT THERAPY STANDARD DOSE THERAPY 2.0 - 3.0 HIGH DOSE THERAPY 2.5 - 3.5 INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Marked elevation of INR in patients receiving oral anticoagulant therapy is a marker of excessive anticoagulation and requires prompt action; an INR below 2.0 reflects insufficient anticoagulation.

Not available

Abnormal LH levels are interpreted with increased or decreased levels of other fertility hormones such as FSH estrogens progesterone and testosterone. Increased LH levels are associated primary ovarian hypogonadism and gonadotropin secreting pituitary tumors. Decreased LH levels are associated with Hypothalamic GnRH deficiency, Pituitary LH deficiency, Ectopic steroid hormone production, GnRH analog treatment. FSH Abnormal FSH levels are interpreted with increased or decreased levels of other fertility hormones such as LH estrogens progesterone and testosterone. Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in males. Decreased FSH levels are associated with primary ovarian hyperfunction in females and primary hypergonadism in males. Normal or decreased FSH levels are associated with polycystic ovary disease in females. COAGULATION CG0001 PROTHROMBIN TIME (PT/INR) REFERENCE GROUP INTERNATIONAL NORMALIZED RATIO (INR) NORMAL POPULATION 0.9 - 1.1 PATIENTS ON ANTICOAGULANT THERAPY STANDARD DOSE THERAPY 2.0 - 3.0 HIGH DOSE THERAPY 2.5 - 3.5 INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Marked elevation of INR in patients receiving oral anticoagulant therapy is a marker of excessive anticoagulation and requires prompt action; an INR below 2.0 reflects insufficient anticoagulation.